A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995

被引:95
作者
Albertsen, PC [1 ]
Walters, S
Hanley, JA
机构
[1] Univ Connecticut, Ctr Hlth, Div Urol, Farmington, CT 06032 USA
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
关键词
prostate; prostatic neoplasms; cause of death; death certificates; mortality;
D O I
10.1016/S0022-5347(05)67915-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: We quantified the agreement between the underlying cause of death determination from information in hospital medical records and on death certificates, and determined whether the frequency of assigning death from prostate cancer had changed since the introduction of testing for prostate specific antigen. Materials and Methods: We retrospectively reviewed and analyzed the information in hospital medical records and on death certificates for men previously diagnosed with prostate cancer who died in 1985 or 1995. Results: The underlying cause of death determinations from a review of 201 hospital medical records agreed with those from information on part 1 of the death certificate in 87% of cases and with those using the International Classification of Diseases-9 system coding rules in 80%. Agreement was higher in men who were older than those who were younger at the time of death, and higher in those diagnosed with prostate cancer several years before death than in those diagnosed shortly before death. Conclusions: There was a high level of agreement concerning the underlying cause of death after a review of the information in hospital medical records and on death certificates for men with prostate cancer when cause of death was viewed as a dichotomous variable. The International Classification of Diseases-9 coding rules concerning the underlying cause of death favor overreporting rather than underreporting prostate cancer deaths compared with a review of hospital medical records. Cause of death determination does not appear to have changed after the introduction of prostate specific antigen testing.
引用
收藏
页码:519 / 523
页数:5
相关论文
共 14 条
[1]
Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Gleason, DF ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980
[2]
The impact of co-morbidity on life expectancy among men with localized prostate cancer [J].
Albertsen, PC ;
Fryback, DG ;
Storer, BE ;
Kolon, TF ;
Fine, J .
JOURNAL OF UROLOGY, 1996, 156 (01) :127-132
[3]
CAUSE-SPECIFIC MORTALITY - UNDERSTANDING UNCERTAIN TIPS OF THE DISEASE ICEBERG [J].
GOLDACRE, MJ .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1993, 47 (06) :491-496
[4]
MEASURES OF MORTALITY IN PROSTATIC-CANCER [J].
GOODMAN, CM ;
RITCHIE, AWS ;
CHISHOLM, GD .
BRITISH JOURNAL OF CANCER, 1990, 61 (03) :465-468
[5]
IS THE APPARENT RISE IN CANCER MORTALITY IN THE ELDERLY REAL - ANALYSIS OF CHANGES IN CERTIFICATION AND CODING OF CAUSE OF DEATH IN ENGLAND AND WALES, 1970-1990 [J].
GRULICH, AE ;
SWERDLOW, AJ ;
SILVA, ID ;
BERAL, V .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) :164-168
[6]
Havlik Richard J., 1992, P262
[7]
Fifteen-year survival in prostate cancer - A prospective, population-based study in Sweden [J].
Johansson, JE ;
Holmberg, L ;
Johansson, S ;
Bergstrom, R ;
Adami, HO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06) :467-471
[8]
Cancer statistics, 1999 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (01) :8-31
[9]
ACCURACY OF CANCER DEATH CERTIFICATES AND ITS EFFECT ON CANCER MORTALITY STATISTICS [J].
PERCY, C ;
STANEK, E ;
GLOECKLER, L .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1981, 71 (03) :242-250
[10]
Ries L, 1998, SEER CANC STAT REV 1